Literature DB >> 804494

Antibodies to cellular antigens in Sjögren's syndrome.

M A Alspaugh, E M Tan.   

Abstract

An extract of human lymphocytes from continous cell culture was used as the antigen source to detect antibodies in sera of patients with Sjögren's syndrome (SS). Using double diffusion in agarose, 85 per cent of a selected group of patients had precepating antibodies. Three precipitating antigen-antibody systems were detected and were shown to be different from those described previously in othe systemic rheumatic diseases. The SS precipitating antibodies were temporarily classified as precipitins, A, B, and C. SS patinets with sicca syndrome but without clinical rheumatoid arthritis had precipitin systems A and/or B, and SS patients with associated rheumatoid arthritis had precipitin system C. Serum reactants were demonstrated by immuno-electrophoresis to migrate in the gamma globulin region. The precipitating activity of the serum factors was not destroyed by treatment with 2-mercaptoethanol and was not removed by absorption of rheumatoid factor from the sera. The reactivity of the lympuocyte antigens was destroyed by treatment with trypsin but not by deoxyribonuclease or ribonuclease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804494      PMCID: PMC301853          DOI: 10.1172/JCI108007

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Precipitating auto-antibodies in the connective tissue diseases.

Authors:  J R ANDERSON; K G GRAY; J S BECK; W W BUCHANAN; A J McELHINNEY
Journal:  Ann Rheum Dis       Date:  1962-12       Impact factor: 19.103

2.  Precipitating autoantibodies in Sjogren's disease.

Authors:  J R ANDERSON; K G GRAY; J S BECK; W F KINNEAR
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

3.  CHARACTERIZATION OF EARLY 19 S AND LATE 7 S IMMUNOGLOBULINS IN THE MOUSE.

Authors:  Y B KIM; S G BRADLEY; D W WATSON
Journal:  J Immunol       Date:  1964-11       Impact factor: 5.422

Review 4.  Sjogren's syndrome. 2. Clinical associations and immunological phenomena.

Authors:  K Whaley; J Webb; B A McAvoy; G R Hughes; P Lee; R N MacSween; W W Buchanan
Journal:  Q J Med       Date:  1973-07

5.  Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome.

Authors:  N Talal; E Zisman; P H Schur
Journal:  Arthritis Rheum       Date:  1968-12

6.  Immunological responses in Sjogren's syndrome and rheumatoid arthritis.

Authors:  K Whaley; A C Glen; R N MacSween; S Deodhar; W C Dick; G Nuki; J Williamson; W W Buchanan
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

7.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

Review 8.  Sjögren's syndrome--newer aspects of research, diagnosis, and therapy.

Authors: 
Journal:  Ann Intern Med       Date:  1971-12       Impact factor: 25.391

9.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  100 in total

1.  Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate.

Authors:  Marvin J Fritzler; Cheryl Hanson; Joan Miller; Theophany Eystathioy
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 2.  Autoantibodies against small cytoplasmic ribonucleoproteins: the anti-Ro/SS-A and anti-La/SS-B autoimmune response. A review of autoantibody detection, autoantigen composition, autoantibody-disease associations and possible etiologic mechanisms.

Authors:  J F Meilof
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  Structure of the La motif: a winged helix domain mediates RNA binding via a conserved aromatic patch.

Authors:  Gang Dong; Ghadiyaram Chakshusmathi; Sandra L Wolin; Karin M Reinisch
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

Review 4.  Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.

Authors:  H M Moutsopoulos; L V Zerva
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Nucleocytoplasmic shuttling of the La motif-containing protein Sro9 might link its nuclear and cytoplasmic functions.

Authors:  Susanne Röther; Cornelia Burkert; Katharina M Brünger; Andreas Mayer; Anja Kieser; Katja Strässer
Journal:  RNA       Date:  2010-05-21       Impact factor: 4.942

6.  Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide.

Authors:  T S Lieu; M M Newkirk; J D Capra; R D Sontheimer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.

Authors:  M Satoh; A K Ajmani; T Ogasawara; J J Langdon; M Hirakata; J Wang; W H Reeves
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Xenopus Ro ribonucleoproteins: members of an evolutionarily conserved class of cytoplasmic ribonucleoproteins.

Authors:  C A O'Brien; K Margelot; S L Wolin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

9.  Mammalian peptidylglycine alpha-amidating monooxygenase mRNA expression can be modulated by the La autoantigen.

Authors:  Fabienne Brenet; Nadège Dussault; Jonas Borch; Géraldine Ferracci; Christine Delfino; Peter Roepstorff; Raymond Miquelis; L'Houcine Ouafik
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Clinical significance of antibodies to ribonucleoprotein.

Authors:  M L Cohen; B Dawkins; R L Dawkins; E T Owen
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.